Technical Analysis for SKYE - Skye Bioscience, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 5.56 | 6.11% | 0.32 |
SKYE closed up 6.11 percent on Friday, November 1, 2024, on 26 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: Nov 11
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| 50 DMA Support | Bullish | 6.11% | |
| Wide Bands | Range Expansion | 6.11% | |
| Overbought Stochastic | Strength | 6.11% | |
| 50 DMA Support | Bullish | 9.23% | |
| Weak + Overbought | Other | 9.23% | |
| Wide Bands | Range Expansion | 9.23% | |
| Overbought Stochastic | Strength | 9.23% | |
| 50 DMA Support | Bullish | 6.51% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 19 hours ago |
| Up 5% | about 23 hours ago |
| Rose Above Previous Day's High | about 24 hours ago |
| Up 3% | about 24 hours ago |
| Up 2% | about 24 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Skye Bioscience, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of cannabinoid-based therapeutics. It focuses on the treatment of a spectrum of diseases, as well as utilizing bioengineering in drug design. Its product pipeline includes SBI-100 and SBI-200. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disease Drug Design
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disease Drug Design
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.4099 |
| 52 Week Low | 1.44 |
| Average Volume | 357,087 |
| 200-Day Moving Average | 8.21 |
| 50-Day Moving Average | 4.95 |
| 20-Day Moving Average | 4.60 |
| 10-Day Moving Average | 5.10 |
| Average True Range | 0.46 |
| RSI (14) | 64.29 |
| ADX | 24.84 |
| +DI | 28.05 |
| -DI | 11.12 |
| Chandelier Exit (Long, 3 ATRs) | 4.18 |
| Chandelier Exit (Short, 3 ATRs) | 4.81 |
| Upper Bollinger Bands | 5.72 |
| Lower Bollinger Band | 3.47 |
| Percent B (%b) | 0.93 |
| BandWidth | 49.05 |
| MACD Line | 0.22 |
| MACD Signal Line | 0.08 |
| MACD Histogram | 0.1386 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.04 | ||||
| Resistance 3 (R3) | 5.99 | 5.78 | 5.96 | ||
| Resistance 2 (R2) | 5.78 | 5.66 | 5.81 | 5.93 | |
| Resistance 1 (R1) | 5.67 | 5.58 | 5.73 | 5.72 | 5.91 |
| Pivot Point | 5.46 | 5.46 | 5.49 | 5.49 | 5.46 |
| Support 1 (S1) | 5.35 | 5.34 | 5.41 | 5.40 | 5.21 |
| Support 2 (S2) | 5.14 | 5.26 | 5.17 | 5.19 | |
| Support 3 (S3) | 5.03 | 5.14 | 5.16 | ||
| Support 4 (S4) | 5.08 |
